18-Hydroxytritriacontan-16-one
CAS: 97191-42-9
Ref. 3D-XDA19142
1mg | Nachfragen | ||
5mg | Nachfragen | ||
10mg | Nachfragen | ||
25mg | Nachfragen | ||
50mg | Nachfragen |
Produktinformation
- 16-Tritriacontanone, 18-hydroxy-
- 18-Hydroxy-16-tritriacontanone
18-Hydroxytritriacontan-16-one is a potent anticancer agent that has been shown to exhibit inhibitory activity towards tumor cells. It acts as a protein kinase inhibitor, which can lead to cell cycle arrest and apoptosis in cancer cells. This compound has demonstrated significant antitumor activity against various types of cancers, making it a promising candidate for cancer treatment. Its mechanism of action involves the inhibition of several key enzymes involved in cell proliferation and survival, including cyclin-dependent kinases and protein kinases. Studies have also shown that 18-Hydroxytritriacontan-16-one exhibits selective toxicity towards cancer cells while sparing normal cells, making it a potentially safer alternative to traditional chemotherapy drugs. Overall, this compound shows great promise as an effective anticancer agent with broad-spectrum activity against many different types of tumors.
Chemische Eigenschaften
Technische Anfrage zu: 3D-XDA19142 18-Hydroxytritriacontan-16-one
Wenn Sie ein Angebot anfordern oder eine Bestellung aufgeben möchten, legen Sie stattdessen die gewünschten Produkte in Ihren Warenkorb und fordern Sie dann ein Angebot oder eine Bestellung an aus dem Warenkorb. Es ist schneller, billiger und Sie können von den verfügbaren Rabatten und anderen Vorteilen profitieren.